Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Azitra Inc Common Stock
(NY:
AZTR
)
0.4080
-0.0118 (-2.81%)
Official Closing Price
Updated: 5:00 PM EST, Dec 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
197,114
Open
0.4000
Bid (Size)
0.4000 (10)
Ask (Size)
0.4072 (584)
Prev. Close
0.4198
Today's Range
0.4000 - 0.4197
52wk Range
0.3803 - 68.40
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Azitra to Present at BIO-Europe 2024
October 29, 2024
From
Azitra, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 24, 2024
Via
Benzinga
Performance
YTD
-98.70%
-98.70%
1 Month
-14.11%
-14.11%
3 Month
-26.62%
-26.62%
6 Month
-89.27%
-89.27%
1 Year
-98.99%
-98.99%
More News
Read More
Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit
October 11, 2024
From
Azitra, Inc.
Via
Business Wire
Why Phoenix Motor Shares Are Trading Higher By 150%; Here Are 20 Stocks Moving Premarket
October 04, 2024
Via
Benzinga
AZTR Stock Earnings: Anitra Reported Results for Q2 2024
August 12, 2024
Via
InvestorPlace
Why Azitra Stock Is Crashing
July 24, 2024
Via
Benzinga
Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress
September 24, 2024
From
Azitra, Inc.
Via
Business Wire
Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors
September 18, 2024
From
Azitra, Inc.
Via
Business Wire
Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 06, 2024
From
Azitra, Inc.
Via
Business Wire
Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome
August 28, 2024
From
Azitra, Inc.
Via
Business Wire
Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors
August 22, 2024
From
Azitra, Inc.
Via
Business Wire
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
August 21, 2024
Via
Benzinga
Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome
August 20, 2024
From
Azitra, Inc.
Via
Business Wire
Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates
August 12, 2024
From
Azitra, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
August 12, 2024
Via
InvestorPlace
CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering
July 25, 2024
From
Azitra, Inc.
Via
Business Wire
Crude Oil Gains 1%; AT&T Shares Rise After Q2 Earnings
July 24, 2024
Via
Benzinga
Exposures
Fossil Fuels
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 24, 2024
Via
Benzinga
Dow Tumbles 300 Points; Tesla Shares Plunge After Q2 Results
July 24, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Nasdaq Down 2%; Alphabet Posts Upbeat Earnings
July 24, 2024
Via
Benzinga
Why Is Conn’s (CONN) Stock Down 36% Today?
July 24, 2024
Via
InvestorPlace
Topics
Bankruptcy
Exposures
Financial
Legal
Why Is Azitra (AZTR) Stock Down 75% Today?
July 24, 2024
Via
InvestorPlace
Topics
Intellectual Property
Exposures
Intellectual Property
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
July 24, 2024
Via
InvestorPlace
Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
July 24, 2024
Via
Benzinga
Azitra, Inc. Announces Pricing of $10.0 Million Public Offering
July 23, 2024
From
Azitra, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.